Met-enkephalins in patients with inflammatory bowel diseases

Advances in Medical Sciences

Volumn 56, Issue 2, 2011, Pages 158-164

  Owczarek, D ^a   Cibor, D ^a   MacH, T ^a   Ciesla A ^a   Pierzchala Koziec K ^b   Salapa K ^a   Kusnierz Cabala B ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

Author keywords

Crohn's disease; met enkephalins; ulcerative colitis

Indexed keywords

METENKEPHALIN;

ADULT; AGED; ARTICLE; COLON BIOPSY; COLON CROHN DISEASE; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; ULCERATIVE COLITIS;

EID: 84855432464     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-011-0051-x     Document Type: Article

References (34)

1. Janson W, Stein C. Peripheral opioid analgesia. Curr Pharm Biotechnol. 2003 Aug;4(4):270-4. (Pubitemid 36958337)
2. Zagon IS, Wu Y, McLaughlin PJ. Opioid growth factor is present in human and mouse gastrointestinal tract and inhibits DNA synthesis. Am J Physiol. 1997 Apr;272(4 Pt 2):R1094-104.
3. Sharp BM. Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun. 2006 Jan;20(1):9-14. (Pubitemid 41814658)
4. Fiset ME, Gilbert C, Poubelle PE, Pouliot M. Human neutrophils as a source of nociceptin: a novel link between pain and infammation. Biochemistry. 2003 Sep 9;42(35):10498-505. (Pubitemid 37071450)
5. Blalock JE. The immune system as the sixth sense. J Intern Med. 2005 Feb;257(2):126-38. (Pubitemid 40193963)
6. Collins S, Verma-Gandhu M. The putative role of endogenous and exogenous opiates in infammatory bowel disease. Gut. 2006 Jun;55(6):756-7. (Pubitemid 43764538)
7. Straub RH, Wolff C, Fassold A, Hofbauer R, Chover-Gonzalez A, Richards LJ, Jessop DS. Antiinfammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis. Arthritis Rheum. 2008 Feb;58(2):456-66. (Pubitemid 351294880)
8. De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil. 2004 Aug;16(4):383-94. (Pubitemid 39140632)
9. Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil. 2004 Oct;16 Suppl 2:17-28. (Pubitemid 39468863)
10. Mosnaim AD, Nguyen TD, Puente J, Wolf ME. Degradation kinetics of methionine5-enkephalin by select brain areas from patients with chronic schizophrenia. Am J Ther. 2008 Mar-Apr;15(2):126-30. (Pubitemid 351450777)
11. McLaughlin PJ, Zagon IS. Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor. Int J Oncol. 2006 Jun;28(6):1577-83.
12. Boyella VD, Nicastri AD, Bergasa NV. Human hepatic met-enkephalin and delta opioid receptor-1 immunoreactivities in viral and autoimmune hepatitis. Ann Hepatol. 2008 Jul-Sep;7(3):221-6.
13. Panerai AE, Sacerdote P. Beta-endorphin in the immune system: a role at last? Immunol Today. 1997 Jul;18(7):317-9. (Pubitemid 27314466)
14. Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS. Low-dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol. 2007 Apr;102(4):820-8. (Pubitemid 46496605)
15. Philippe D, Chakass D, Thuru X, Zerbib P, Tsicopoulos A, Geboes K, Bulois P, Breisse M, Vorng H, Gay J, Colombel JF, Desreumaux P, Chamaillard M. Mu opioid receptor expression is increased in infammatory bowel diseases: implications for homeostatic intestinal infammation. Gut. 2006 Jun;55(6):815-23. (Pubitemid 43764552)
16. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classifcation of infammatory bowel disease: controversies, consensus, and implications. Gut. 2006 Jun;55(6):749-53.
17. Rentsch M, Beham A, Schlitt HJ, Jauch KW. Crohn's disease activity index and Vienna classifcation-is it worthwhile to calculate before surgery? Dig Surg. 2006;23(4):241-9. (Pubitemid 44651424)
18. van Deventer SJ, Tami JA, Wedel MK. A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis. Gut. 2004 Nov;53(11):1646-51. (Pubitemid 39434109)
19. Pierzchala K, Van Loon GR. Plasma native and peptidase-derivable Met-enkephalin responses to restraint stress in rats. Adaptation to repeated restraint. J Clin Invest. 1990 Mar;85(3):861-73. (Pubitemid 20087490)
20. Roy S, Barke RA, Loh HH. MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res. 1998 Oct 30;61(1-2):190-4. (Pubitemid 28511362)
21. Gomez-Flores R, Suo JL, Weber RJ. Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray. Brain Behav Immun. 1999 Sep;13(3):212-24. (Pubitemid 29450199)
22. Wang J, Charboneau R, Balasubramanian S, Barke RA, Loh HH, Roy S. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J Leukoc Biol. 2002 May;71(5):782-90.
23. Sacerdote P. Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages. Ann N Y Acad Sci. 2003 May;992:129-40. (Pubitemid 36706643)
24. Wiedermann CJ, Sacerdote P, Propst A, Propst T, Judmaier G, Kathrein H, Vogel W, Panerai AE. Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease. Brain Behav Immun. 1994 Sep;8(3):261-9. (Pubitemid 24344874)
25. Koch TR, Carney JA, Go VL. Distribution and quantitation of gut neuropeptides in normal intestine and infammatory bowel diseases. Dig Dis Sci. 1987 Apr;32(4):369-76. (Pubitemid 17061265)
26. Philippe D, Dubuquoy L, Groux H, Brun V, Chuoï-Mariot MT, Gaveriaux-Ruff C, Colombel JF, Kieffer BL, Desreumaux P. Anti-infammatory properties of the mu opioid receptor support its use in the treatment of colon infammation. J Clin Invest. 2003 May;111(9):1329-38. (Pubitemid 36554703)
27. Van Assche G, Rutgeerts P. Physiological basis for novel drug therapies used to treat the infammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in infammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G169-74. (Pubitemid 40129566)
28. Gibson G, Foulis AK, Bovell DL, Corbett AD. Immunohistochemical localisation of Metenkephalin in the normal human colon and infammatory bowel disease. J. Physiol. 2004;557P, PC37.
29. Spetea M, Rydelius G, Nylander I, Ahmed M, Bileviciute-Ljungar I, Lundeberg T, Svensson S, Kreicbergs A. Alteration in endogenous opioid systems due to chronic infammatory pain conditions. Eur J Pharmacol. 2002 Jan 25;435(2-3):245-52. (Pubitemid 34131707)
30. Jessop DS, Richards LJ, Harbuz MS. Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of infammation. Ann N Y Acad Sci. 2002 Jun;966:456-63. (Pubitemid 34729206)
31. Rittner HL, Brack A, Machelska H, Mousa SA, Bauer M, Schäfer M, Stein C. Opioid peptide-expressing leukocytes: identifcation, recruitment, and simultaneously increasing inhibition of infammatory pain. Anesthesiology. 2001 Aug;95(2):500-8. (Pubitemid 32720742)
32. Chadzinska M, Scislowska-Czarnecka A, Pierzchala-Koziec K, Plytycz B. Infammation-induced alternations in local and central Met-enkephalin in mice. Pol J Pharmacol. 2003 May-Jun;55(3):467-70. (Pubitemid 36975216)
33. Pol O, Sasaki M, Jiménez N, Dawson VL, Dawson TM, Puig MM. The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal infammation in mice. Br J Pharmacol. 2005 Jul;145(6):758-66. (Pubitemid 41076282)
34. Tegeder I, Geisslinger G. Opioids as modulators of cell death and survival-unraveling mechanisms and revealing new indications. Pharmacol Rev. 2004 Sep;56(3):351-69. (Pubitemid 39096595)